Dror Ortho-Design, Inc.

DROR ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $-2.5M $-5.8M $-3.6M $-1.7M $-170.5K $-168.0K $-134.2K $-115.9K
Depreciation & Amortization — — — — — — — —
Depreciation $4.9K $4.0K $670 $670 — — — —
Amortization — — — — — — — —
Stock-Based Compensation $39.2K $2.2M $2.3M $19.9K — — — —
Net Cash from Operating Activities $-2.1M $-2.7M $-2.4M $-1.5M $-136.1K $-109.7K $-76.8K $-66.5K
Investing Activities
Capital Expenditures $966 $25.8K — — — — — —
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-966 $-25.8K $18.0K — — — — —
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $1.8M — $4.7M — — — — —
Net Change in Cash $-320.9K $-2.8M $2.3M $-1.5M — $-109.7K $-76.8K $-66.5K
Free Cash Flow $-2.1M $-2.8M — — — — — —